Immunovant, Inc.
IMVT
Jodie situation report
Immunovant, Inc.'s move is being confirmed by its market group.
IMVT accounts for 2.3% of the group's measured movement across 8.4 effective names. raw member direction is mixed; 8 of 12 session-normalized paths align to the upside. Capital-flow agreement is 17%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
No material onset for IMVT could be timestamped inside the aligned 5-minute window.
14 of 18 members in Biotech Rare Diseases are active. 0 of 4 disclosed connections are confirming.
- At least 12 of 18 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as ROIV begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.
Who this business touches
The relationships behind IMVT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ROIVRoivant Sciences Ltd.partnerMay 20, 2026 ▾
“108 Table of Contents Unallocated costs include: • personnel-related expenses, such as salaries, stock-based compensation and benefits, for research and development personnel; • costs allocated to us under our services agreements with Roivant Sciences Ltd.”
Depended on by
ROIVRoivant Sciences Ltd.partnerMay 20, 2026 ▾
“Vant / Licensor Product Candidate Milestones Royalties Priovant / Pfizer Brepocitinib • Mid-tens-of-millions sales milestone payment if aggregate net sales in a given year exceed a mid-hundreds-of-millions amount • Tiered sub-teens royalty on net sales Immuno…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
IMVT is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.